(Q37653001)

21 August 2017

title

Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy (English)

1 reference

21 August 2017

0 references

R E Eilers

1

1 reference

21 August 2017

M Gandhi

2

1 reference

21 August 2017

J D Patel

3

1 reference

21 August 2017

M F Mulcahy

4

1 reference

21 August 2017

M Agulnik

5

1 reference

21 August 2017

T Hensing

6

1 reference

21 August 2017

Mario E Lacouture

7

1 reference

21 August 2017

language of work or name

English

0 references

publication date

9 December 2009

1 reference

Journal of the National Cancer Institute

21 August 2017

published in

1 reference

21 August 2017

volume

102

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

47-53

1 reference

Mechanisms of cutaneous toxicities to EGFR inhibitors.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP439

Oral chemotherapeutic agents: understanding mechanisms of action and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP439

Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP439

Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP439

Staphylococcus aureus bacteremia secondary to severe erlotinib skin toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP439

How important is the pus culture obtained from epithelial growth factor receptor (EGFR) inhibitors' associated rash?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP439

Molecular diagnosis in dermatopathology: what makes sense, and what doesn't

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP439

A U.S. population-based survey of Staphylococcus aureus colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP439

Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP439

Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP439

Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP439

MRSA patients: proven methods to treat colonization and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP439

Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP439

Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP439

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP439

High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP439

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJP439

1 reference

21 August 2017

1 reference